The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study.
Imke RedekerBritta SiegmundKamran GhoreschiUwe PleyerJohanna CallhoffFalk HoffmannUrsula MarschallHildrun HaibelJoachim SieperAngela ZinkDenis PoddubnyyPublished in: Therapeutic advances in musculoskeletal disease (2020)
Disease activity is higher in patients with axSpA with history of IBD or history of PSO. Functional impairment is also higher in patients with axSpA with history of PSO. The presence of different EMMs was associated with different treatment patterns in axSpA.